Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
+91.4%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
7x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $85.41M | +294.5% |
| 2024 | $-43.92M | -92.2% |
| 2023 | $-22.86M | -287.7% |
| 2022 | $12.18M | +107.9% |
| 2021 | $-154.28M | -1.2% |
| 2020 | $-152.42M | +5.1% |
| 2019 | $-160.63M | -48.9% |
| 2018 | $-107.87M | -65.0% |
| 2017 | $-65.37M | -172.6% |
| 2016 | $-23.98M | - |